A detailed history of Dimensional Fund Advisors LP transactions in Hille Vax, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 72,581 shares of HLVX stock, worth $140,081. This represents 0.0% of its overall portfolio holdings.

Number of Shares
72,581
Previous 152,602 52.44%
Holding current value
$140,081
Previous $2.21 Million 94.24%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$1.58 - $14.42 $126,433 - $1.15 Million
-80,021 Reduced 52.44%
72,581 $127,000
Q2 2024

Aug 09, 2024

BUY
$11.86 - $15.93 $435,143 - $584,471
36,690 Added 31.65%
152,602 $2.21 Million
Q1 2024

May 10, 2024

BUY
$14.15 - $19.75 $726,560 - $1.01 Million
51,347 Added 79.53%
115,912 $1.93 Million
Q4 2023

Feb 07, 2024

BUY
$10.35 - $17.11 $668,247 - $1.1 Million
64,565 New
64,565 $1.04 Million

Others Institutions Holding HLVX

About HilleVax, Inc.


  • Ticker HLVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,427,200
  • Market Cap $64.5M
  • Description
  • HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
More about HLVX
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.